当前位置:药药网 / 数据中心 / 生物制药海外临床研究状况
CD19 Targeted CAR T Cell Therapy in Patients With Relapsed/ Refractory B Cell Acute Lymphoblastic Leukaemia (ALL)
标题(英文)
CD19 Targeted CAR T Cell Therapy in Patients With Relapsed/ Refractory B Cell Acute Lymphoblastic Leukaemia (ALL)
条件
Relapsed B Cell Acute Lymphoblastic Leukemia (ALL)|Refractory B Cell Acute Lymphoblastic Leukemia (ALL)
干预
Biological: CD19 CAR engineered autologous T-cells|Drug: Cyclophosphamide|Drug: Fludarabine|Drug: Mesna